LONG-TERM OUTCOME COMPARISON OF DRUG-ELUTING STENTS AND BARE-METAL STENTS IN PATIENTS WITH HIGH BLEEDING RISK

There has been an increased use of drug-eluting stents (DES) for percutaneous coronary intervention (PCI). It was considered that patients with DES needed longer dual anti-platelet therapy (DAPT) than those with bare-metal stents (BMS) to prevent stent thrombosis. Although longer DAPT duration may